Table 1.
(a,b) Basic characteristics of organ recipients from standard versus marginal donors.
| SDs (n = 174) | MDs (n = 64) | p | |
|---|---|---|---|
| n (%) or Median (IQR) | n (%) or Median (IQR) | ||
| (a) | |||
| Gender (Female) | 39 (22.4%) | 17 (26.6%) | 0.5 |
| Age (years) | 56.4 (46.8–63.3) | 63.6 (55.3–66.8) | <0.001 |
| Cardiac diagnosis | 0.5 | ||
| Dilatative | 67 (38.5%) | 18 (28.1%) | |
| Ischemic | 71 (40.8%) | 33 (51.6%) | |
| Congenital | 12 (6.9%) | 3 (4.7%) | |
| Valvular | 3 (1.7%) | 2 (3.1%) | |
| Hypertrophic | 10 (5.7%) | 2 (3.1%) | |
| Other | 11 (6.3%) | 6 (9.4%) | |
| BSA (m2) | 1.7 (1.7–2.0) | 1.8 (1.7–1.9) | 0.6 |
| Dyslipidemia | 63 (36.2%) | 25 (39.1%) | 0.8 |
| Hypertension | 62 (35.6%) | 33 (51.6%) | 0.04 |
| Cancer | 9 (5.2%) | 2 (3.1%) | 0.7 |
| Diabetes | 31 (17.8%) | 16 (25.0%) | 0.3 |
| PVD | 12 (6.9%) | 7 (10.9%) | 0.2 |
| COPD | 10 (5.7%) | 13 (20.3%) | 0.002 |
| ICD | 129 (74.1%) | 54 (84.4%) | 0.1 |
| Cerebral event | 28 (16.1%) | 16 (25.0%) | 0.1 |
| Smoker | 63 (36.2%) | 23 (35.9%) | 0.6 |
| Genetic syndrome | 11 (6.3%) | 3 (4.7%) | 0.8 |
| Previous cardiac surgery | 67 (38.5%) | 32 (50.0%) | 0.1 |
| Bilirubin (µmol/L) | 14.6 (9.3–22.6) | 15.0 (7.2–22.7) | 0.3 |
| GFR (mL/min/mq) | 71.0 (49.0–89.0) | 51.0 (44.0–68.0) | 0.03 |
| (b) | |||
| Intracorporeal LVAD | 49 (28.2%) | 19 (29.7%) | |
| Length of LVAD support (months) | 13.1 (4.8–31.6) | 19.0 (13.7–28.0) | 0.4 |
| List status | 0.02 | ||
| 2B | 74 (42.5%) | 28 (43.8%) | |
| 2A | 51 (29.3%) | 21 (32.8%) | |
| 1 | 5 (2.9%) | 7 (10.9%) | |
| HU | 44 (25.3%) | 8 (12.5%) | |
| Status 1 + HU | 49 (28.2%) | 15 (23.4%) | 0.5 |
| Waiting list time (months) | 4.8 (1.1–18.1) | 6.5 (2.2–21.6) | 0.5 |
| ICU-stay | 62 (35.6%) | 15 (23.4%) | 0.2 |
| Inotropic support | 47 (27.0%) | 15 (23.4%) | 0.6 |
| Mechanical ventilation | 7 (4.0%) | 4 (6.3%) | 0.5 |
| CVVH | 8 (4.6%) | 3 (4.7%) | 0.9 |
| Temporary-MCS | 42 (24.14%) | 8 (12.5%) | 0.2 |
| IABP | 1 (0.6%) | 0 (0.0%) | 0.9 |
| ECMO | 18 (10.3%) | 3 (4.7%) | 0.2 |
| Paracorporeal-LVAD | 12 (6.9%) | 3 (4.7%) | 0.8 |
| Paracorporeal-RVAD | 3 (1.7%) | 1 (1.6%) | 0.8 |
| Paracorporeal-BiVAD | 8 (4.6%) | 1 (1.6%) | 0.5 |
Abbreviations: BSA, body surface area; COPD, chronic obstructive pulmonary disease; CVVH, continuous venovenous hemofiltration; ECMO, extracorporeal membrane oxygenator; GFR, glomerular filtration rate; HU, high urgency; IABP, intra-aortic balloon pump; ICD, implantable cardioverter defibrillator; ICU, intensive care unit; LVAD, left ventricular assistance device; MCS, mechanical circulatory support; PVD, peripheral vascular disease, RVAD, right ventricular assist device.